Others

  • Publications
  • Others

OTHER ORIGINAL ARTICLES

Since 2012

  1. Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ, Yoo C, Yi K, Kim KH, Eo S, Moon DB, Hong SM, Ju YS, Shin EC, Hwang S, Park SH. Association between expression level of PD1 by tumor-infiltrating CD8+ T cells and features of hepatocellular carcinoma. Gastroenterology 155:1936-1950, 2018
  2. Kim S, Kim HS, Kim E, Lee MG, Shin EC, Paik S, Kim S. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information. Ann Oncol 29:1030-1036, 2018
  3. Hong KH, Choi JP, Hong SH, Lee J, Kwon JS, Kim SM, Park SY, Rhee JY, Kim BN, Choi HJ, Shin EC, Pai H, Park SH, Kim SH. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax 73:286-289, 2018
  4. Kim WJ, Koo JH, Cho HJ, Lee JU, Kim JY, Lee HG, Lee S, Kim JH, Oh MS, Suh M, Shin EC, Ko JY, Sohn MH, Choi JM. Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, AP-rPTP alleviates both atopic dermatitis-like and psoriasis-like dermatitis. J Allergy Clin Immunol 141:137-151, 2018
  5. Kwon JS, Kim T, Kim SM, Sung H, Shin S, Kim YH, Shin EC, Kim SH, Han DJ. Comparison of the commercial QuantiFERON-CMV and overlapping peptide-based ELISPOT assays for predicting CMV infection in kidney transplant recipients. Immune Netw 17:317-325, 2017
  6. Kim HJ, Lim J, Jang YS, Shin EC, Kim HR, Seoh JY, Lee JS, Lee SN, Kang JL, Choi YH. Exogenous hydrogen peroxide induces lipid raft-mediated STAT-6 activation in T cells. Cell Physiol Biochem 42:2467-2480, 2017
  7. Kim KJ, Kim JH, Lee SJ, Lee EJ, Shin EC, Seong J. Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model. Oncotarget 8:41242-41255, 2017
  8. Kim D, Kim HJ, Shim SB, Jung S, Lee NH, Nahm SH, Shin EC, Yun WS, Ha DH. Electrical conductance change of graphene-based devices upon surface modification for detecting botulinum neurotoxin. Jpn J Appl Phys 56:067001, 2017
  9. Lim KJ, Lee SJ, Kim S, Lee SY, Lee MS, Park YA, Choi EJ, Lee EB, Jun HK, Cho JM, Lee S, Kwon KS, Lim BP, Jeon MS, Shin EC, Choi YS, Fudim E, Picard O, Yavzori M, Ben-Horin S, Chang SJ. Comparable immune function inhibition by the infliximab biosimilar CT-P13: implications for treatment of inflammatory bowel disease. J Crohns Colitis 11:593-602, 2017
  10. Kim JH, Sung PS, Lee EB, Hur W, Park DJ, Shin EC, Windisch MP, Yoon SK. GRIM-19 restricts HCV replication by attenuating intracellular lipid accumulation. Front Microbiol 8:576, 2017
  11. Lee M, Yang J, Jo E, Lee JY, Kim HY, Bartenschlager R, Shin EC, Bae YS, Windisch MP. A novel inhibitor IDPP interferes with entry and egress of HCV by targeting glycoprotein E1 in a genotype-specific manner. Sci Rep 7:44676, 2017
  12. Kim S, Choe JH, Lee GJ, Kim YS, Kim SY, Lee HM, Jin HS, Kim TS, Kim JM, Cho MJ, Shin EC, Jo EK, Kim JS. Ionizing radiation induces innate immune responses in macrophages by generation of mitochondrial reactive oxygen species. Radiat Res 187:32-41, 2017
  13. Shin M, Park SG, Oh BC, Kim K, Jo S, Lee MS, Oh SS, Hong SH, Shin EC, Kim KS, Kang SW, Lee H. Complete prevention of blood loss with self-sealing haemostatic needles. Nat Mater 16:147-152, 2017
  14. Park SJ, Si YJ, Kim J, Song MS, Kim SM, Kim EH, Kwon HI, Kim YI, Lee OJ, Shin OS, Kim CJ, Shin EC, Choi YK. Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus. Virology 498:36-43, 2016
  15. Jung GS, Jeon JH, Choi YK, Jang SY, Park SY, Kim SW, Byun JK, Kim MK, Lee S, Shin EC, Lee IK, Kang YN, Park KG. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. Sci Rep 6:30846, 2016
  16. Kim GW, Lee SH, Cho H, Kim M, Shin EC, Oh JW. Hepatitis C virus core protein promotes miR-122 destabilization by inhibiting GLD-2. PLoS Pathog 12:e1005714, 2016
  17. Youn JC, Lee HS, Choi SW, Han SW, Ryu KH, Shin EC, Kang SM. Post-exercise heart rate recovery independently predicts clinical outcome in patients with acute decompensated heart failure. Plos One 11:e0154534, 2016
  18. Kim N, Kim MJ, Sung PS, Bae YC, Shin EC, Yoo JY. Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5A. Nat Commun 7:10631, 2016
  19. Park C, Min S, Park EM, Lim YS, Kang S, Suzuki T, Shin EC, Hwang SB. Pim kinase interacts with nonstructural 5A protein and regulates hepatitis C virus entry. J Virol 89:10073-10086, 2015
  20. Jung GS, Jeon JH, Choi YK, Jang SY, Park SY, Kim MK, Shin EC, Jeong WI, Lee IK, Kang YN, Park KG. Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells. Liver Int 35:2233-2245, 2015
  21. Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T. Amino acid polymorphisms in hepatitis C virus core affect infectious virus production and major histocompatibility complex class I molecule expression. Sci Rep 5:13994, 2015
  22. Moon SH, Shin EC, Noh YW, Lim YT. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine. Vaccine 33:4762-4769, 2015
  23. Yu HT, Lee J, Shin EC, Park S. Significant association between serum monokine induced by gamma interferon and carotid intima media thickness. J Atheroscler Thromb 22:816-822, 2015
  24. Park S, Kim J, Ock H, Dutta G, Seo J, Shin EC, Yang H. Sensitive electrochemical detection of vaccinia virus in a solution containing a high concentration of l-ascorbic acid. Analyst 140:5481-5487, 2015
  25. Shin C, Han JA, Koh H, Choi B, Cho Y, Jeong H, Ra JS, Sung PS, Shin EC, Ryu S, Do Y. CD8α– dendritic cells induce antigen-specific T follicular helper cells generating efficient humoral immune responses. Cell Rep 11:1929-1940, 2015
  26. Park JP, Koh MY, Sung PS, Kim K, Kim MS, Lee MS, Shin EC, Kim KH, Lee H. Inactivation efficiency of DNA and RNA viruses during chitin-to-chitosan conversion. Macromol Res 23:505-508, 2015
  27. Lee HW, Chang DY, Moon HJ, Chang HY, Shin EC, Lee JS, Kim KA, Kim HJ. Clinical factors and viral load influencing severity of acute hepatitis A. Plos One 10:e0130728, 2015
  28. Yu HT, Oh J, Chang HJ, Lee SH, Shin EC, Park S. Serum monokine induced by gamma interferon as a novel biomarker for coronary artery calcification in humans. Coron Artery Dis 26:317-321, 2015
  29. Kim DK, Park MH, Chang DY, Eun KM, Shin HW, Mo JH, Shin EC, Jin HR, Shin S, Roh EY, Han DH, Kim DW. MBP-positive and CD11c-positive cells are associated with different phenotypes of Korean patients with non-asthmatic chronic rhinosinusitis. Plos One 9:e111352, 2014
  30. Ahn S, Lee IH, Kang S, Kim D, Choi M, Saw PE, Shin EC, Jon S. Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapy. Adv Healthc Mater 3:1194-1199, 2014
  31. Kwon JS, Yoon J, Kim YJ, Kang K, Woo S, Jung DI, Song MK, Kim EH, Kwon HI, Choi YK, Kim J, Lee J, Yoon Y, Shin EC, Youn JW. Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection. Eur J Immunol 44:2360-2369, 2014
  32. Choi JE, Hur W, Kim JH, Li TZ, Lee EB, Lee SW, Kang W, Shin EC, Wakita T, Yoon SK. MicroRNA-27a modulates HCV infection in differentiated hepatocyte-like cells from adipose tissue-derived mesenchymal stem cells. Plos One 9:e91958, 2014
  33. Jin J, Chang DY, Kim SH, Rha KS, Mo JH, Shin EC, Kim YM. Role of hypoxia-inducible factor-1a expression in regulatory T cells on nasal polypogenesis. Laryngoscope 124:E151-159, 2014
  34. Park SJ, Kim EH, Pascua PN, Kwon HI, Lim GJ, Decano A, Kim SM, Song MK, Shin EC, Choi YK. Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models. J Gen Virol 95:793-798, 2014
  35. Seo J, Kim K, Chang DY, Kang HB, Shin EC, Kwon J, Choi JK. Genome-wide reorganization of histone H2AX towards particular fragile sites on cell activation. Nucleic Acids Res 42:1016-1025, 2014
  36. Park SH, Veerapu NS, Shin EC, Biancotto A, McCoy JP, Capone S, Folgori A, Rehermann B. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med 19:1638-1642, 2013
  37. Jeon JW, Park BC, Jung JG, Jang YS, Shin EC, Park YW. The soluble form of the cellular prion protein enhances phagocytic activity and cytokine production by human monocytes via activation of ERK and NF-k Immune Netw 13:148-156, 2013
  38. Kim SU, Song KJ, Chang HY, Shin EC, Park JY, Kim do Y, Han KH, Chon CY, Ahn SH. Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. Plos One 8:e69166, 2013
  39. Kim SW, Kim DW, Khalmuratova R, Kim JH, Jung MH, Chang DY, Shin EC, Lee HK, Shin HW, Rhee CS, Jeon SY, Min YG. Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model. Allergy 68:862-869, 2013
  40. Song MS, Cho YH, Park SJ, Pascua PN, Baek YH, Kwon HI, Lee OJ, Kong BW, Kim H, Shin EC, Kim CJ, Choi YK. Early regulation of viral infection reduces inflammation and rescues Mx-positive mice from lethal avian influenza infection. Am J Pathol 182:1308-1321, 2013
  41. Shin EC, Park SH, Nascimbeni M, Major M, Caggiari L, de Re V, Feinstone SM, Rice CM, Rehermann B. The frequency of CD127+ hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predict the outcome of acute HCV infection. J Virol 87:4772-4777, 2013
  42. Park J, Lee J, Kang W, Chang S, Shin EC, Choi C. TGF-b1 and hypoxia-dependent expression of MKP-1 leads tumor resistance to death receptor-mediated cell death. Cell Death Dis 4:e521, 2013
  43. Park SH, Shin EC, Capone S, Caggiari L, De Re V, Nicosia A, Folgori A, Rehermann B. Successful vaccination induces multifunctional memory T cell precursors associated with early hepatitis C virus control. Gastroenterology 143:1048-1060, 2012